- merger, acquisition and takeover
Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million
CHICAGO, July 23, 2024 /PRNewswire/ -- Valinor Pharma, LLC ("Valinor") announced today it was purchased by Grünenthal for a total deal value of approximately $250 million in upfront cash consideration.
Read more